このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effects of Ketogenic Diet on Alcohol Intoxication

2026年8月3日 更新者:University of Pennsylvania
The research study is being conducted to better understand the effects of ketosis on brain functioning and the acute effects of alcohol. Participants will be asked to undergo ~4 weeks of ketogenic diet intervention. The study involves three lab visits: Lab 1 before starting the diet, Lab 2 after about 2 weeks after starting the diet, and Lab 3 after being on the diet for 4 weeks. All of the labs will include an alcohol tolerance test, and blood draws. Lab 1 and Lab 3 will also include an Magnetic resonance imaging scan. Due to scheduling, study procedures at 2 and 4 weeks may occur +/- 3 days. Magnetic resonance imaging (MRI) of the brain will measure levels of nicotinamide adenine dinucleotide (NAD) (a coenzyme that is important for energy metabolism), lactate (a metabolite produced during energy metabolism), and neurotransmitters glutamate and GABA. Alcohol tolerance will be tested using a dose of alcohol (approximately 4-5 alcohol beverages) to will elevate breath alcohol levels to approximately 0.08% to measure the acute effects of alcohol. Blood samples will be collected to measure varying metabolites.

調査の概要

詳細な説明

Consent and Screening Session (approximately 4 hours).

The following will occur at this visit. The visit may be completed on more than one day at the CSA following signed consent:

  • Participants will be asked to show a legal photo ID and then undergo a breathalyzer test to ensure that they are able to make a well-reasoned decision about whether or not to participate in the study. The breath alcohol level must be 0.000% to sign the consent form.
  • Participants will be asked to provide demographic information, including current address to be registered as a patient at the University of Pennsylvania.
  • A clinician will perform a medical history and physical examination. Trained study staff will draw a total of approximately 3 tablespoons (44 mL) of blood for standard laboratory tests and genetic analysis.
  • A urine sample is required for routine urinalysis, drug screen, ketone levels, and a pregnancy test for woman who are able to become pregnant.
  • Study personnel will measure vital signs (blood pressure and pulse), weight, and height.
  • Study personnel will complete a brief psychiatric interview record alcohol and cigarette use over the past 90 days.
  • Participants must complete a screening evaluation form in advance of the MRI exam for the presence of medical implants or other foreign bodies that could pose an injury when undergoing MRI.

Staff will call participants within 5 business days of completing the screening visit to confirm whether study eligibility and schedule the rest of the study visits.

Dietary Intervention (4 weeks each)

Participants will be asked to adhere to a 4-weeks ketogenic diet. Depending on scheduling availability, in may include an additional 3 days. All meals will be provided by a commercial meal service (Factor75) and will be delivered to participants residence weekly. Participants are asked to just eat the food provided for the 4-weeks of the study. Compliance to the dietary intervention will be assessed daily with a urine ketone levels test that will be performed each morning. A picture of the test will be sent by text or email daily. Blood ketone levels will be checked on the days of the lab visits. Each week a staff member will call participants to check on their health and wellbeing, make sure they are receiving study meals and record the amounts of each meal consumed during the week. Staff will also ask questions about mood and record alcohol use for each week.

Study lab visits lab 1 and 3 (week 4; approximately 8 hours. each) Staff will call the night before to reminder participants not to eat or drink anything except water after midnight the day before and on the day of the study visit. The study will provide breakfast and lunch. Staff will review the current list medications and vitamins provided at the screening visit, and will inquire about any changes.

Lyft ride service will be used to bring participants to Stellar Chance Laboratories (440 Curie Blvd.).

On the day of the study lab visits, the following will occur:

  • A light meal will be provided, participants must have a breath alcohol level of 0.000% to continue, finger stick for blood glucose level, and vital signs. Participants will be asked about recent use of drugs, alcohol, and nicotine. Staff will collect a urine sample to conduct a drug screen, urine ketone level, and a pregnancy test (for woman able to become pregnant).
  • A brain 7-Tesla MRI scan (~1.5 hour) will be performed. An MRI is a type of scan that uses radio waves to take detailed pictures of the body. Participants will be asked to lie on an MRI table where the technologist will place a receiver on the head. A blanket can be provided for comfort and earplugs since the MRI makes noises while it is scanning. Participants will still be able to hear some sound to ensure communication with the technologist and can follow any direction given throughout the MRI scan. The technologist will slowly slide participants into the MRI magnet where radio waves will be transmitted into the head.

Participants will be asked to:

  • fill out an MRI safety form.
  • remove any metal from the body.
  • Staff will provide earplugs for the noise from the MRI scanner, and position participants on the imaging table with their head in the scanner, held comfortably in a special head holder.
  • Participants will be instructed not to move the head and to lie as still as possible during the scan (~ 90 minutes). There will be several scans, during which staff will obtain a structure image of the brain, NAD (a cofactor involved in energy metabolism), lactate (a byproduct of energy metabolism) and neurotransmitter GABA and glutamate.

After the scan Lyft will be used to travel to 3535 Market St. for the reminder of the laboratory visit.

  • A blood sample will be collected, and lunch will be provided
  • A dose of alcohol calculated to elevate breath alcohol concentration to approximately 0.08% will be provided. Staff will measure alcohol intoxication prior to and at pre-specified times following alcohol administration using the following measurements: breath alcohol concentration, motor (groove pegboard task) and cognitive (go-no-go task) tests, and questionnaires. Study personnel will ask about side effects that may have occurred throughout the laboratory procedures.
  • At the end of the laboratory procedures, participants will be provided a snack and staff will measure blood glucose and ketone levels. Participants will return home by Lyft.

Study lab visit 2 (week 2; approximately 5 hours.) Staff will call the day before to reminder participants not to drink alcohol after 10pm the night before and set up a Lyft ride to 3535 Market St. Participants are asked to eat breakfast at home before coming to the visit. Staff will review the current list medications and vitamins provided at the last study visit, and record any changes.

On the day of the study lab visits, the following will occur:

  • Staff will record participants breath alcohol level (must be 0.000% to continue), finger stick for blood glucose level, and vital signs. Staff will ask about recent use of drugs, alcohol, and nicotine. Participants will be asked to provide a urine sample to conduct a drug screen, urine ketone level, and a pregnancy test (for woman able to become pregnant).
  • Blood sample will be collected, and lunch will be provided
  • A dose of alcohol calculated to elevate breath alcohol concentration to approximately 0.08% will be provided. Staff will measure alcohol intoxication prior to and at pre-specified times following alcohol administration using the following measurements: breath alcohol concentration, motor (groove pegboard task) and cognitive (go-no-go task) tests, and questionnaires. Study personnel will ask about side effects throughout the laboratory procedures.
  • At the end of the laboratory procedures, a snack will be provided and staff will measure blood glucose and ketone levels. Participants will return home by Lyft.

研究の種類

介入

入学 (推定)

20

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Pennsylvania
      • Philadelphia、Pennsylvania、アメリカ、19104
        • 募集
        • Center for Studies of Addiction
        • 副調査官:
          • Cindy Li, Ph.D.
        • コンタクト:
        • 主任研究者:
          • Corinde Wiers, Ph.D

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  1. Age 21 years to 50 years old.
  2. Willingness to provide signed, informed consent and commit to completing study procedures. Reported on at least one day in the month prior to consent of consuming 2 or more standard alcohol drinks on a single day.

Exclusion Criteria:

  1. Unwilling or unable to refrain from use, within 24 hours of the alcohol lab procedures, psychoactive medications or medication that may affect study results.
  2. Current DSM-5 diagnosis of any major psychiatric disorder (other than nicotine use disorders, or marijuana use disorders) as identified by clinical examination or structured interview that could interfere with study participation or make it hazardous for the subject.
  3. Currently taking medication(s) that could interfere with study participation or make it hazardous for the subject to participate. (e.g. anticholinergics; antipsychotics; lithium; psychotropic drugs not otherwise specified)
  4. Positive urine drug screen, positive for all substances but marijuana at screening or study visits (may be repeated once and if the result is negative on repeat, it is not exclusionary).
  5. A current, clinically significant physical disease or abnormality on the basis of medical history, or routine laboratory evaluation that can impact brain function, the use of a ketone supplement, administration of ketogenic diet, or the use of alcohol (e.g., epilepsy, diabetes, irritable bowel syndrome, Crohn's disease, liver disease, kidney disease, kidney stones, chronic metabolic acidosis or a cardiomyopathy as determined by history and clinical exam).
  6. Currently suffering from or has a history of stroke and/or stroke related spasticity.
  7. Head trauma with loss of consciousness for more than 30 minutes or associated with skull fracture, inter-cranial bleeding or abnormal MRI (self-report, medical history).
  8. Weight greater than 225lbs (Need to cap amount of alcohol given based on weight to individuals).
  9. Females who are pregnant or breast-feeding
  10. Contraindication to MRI, including presence of ferromagnetic objects, claustrophobia or fear of enclosed, medical conditions that prevent subjects from lying comfortably flat on his/ her back for up to 2 hrs.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Ketogenic diet
4 week ketogenic diet intervention
4 week ketogenic diet

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Effects of ketogenic diet on cerebral levels of glutamate.
時間枠:4 weeks
Glutamate levels will be measures with magnetic resonance imaging prior to and after the 4 week ketogenic diet.
4 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Effects of ketogenic diet on Breath alcohol levels
時間枠:4 hours
Breath alcohol levels will be measures during the alcohol tolerance lab prior to and after 4 weeks ketogenic diet.
4 hours

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Corinde Wiers, Ph.D.、University of Pennsylvania
  • スタディディレクター:Henry Kranzler, MD、University of Pennsylvania

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年5月14日

一次修了 (推定)

2027年8月31日

研究の完了 (推定)

2030年5月1日

試験登録日

最初に提出

2026年5月15日

QC基準を満たした最初の提出物

2026年5月15日

最初の投稿 (実際)

2026年5月22日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月4日

QC基準を満たした最後の更新が送信されました

2026年8月3日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する